Key Points
- North America dominated the kidney stone management market globally in the previous year of 2023, and it is poised to hold its position during the forecast period.
- Asia Pacific is an expanding market and is projected to hold a significant market share in 2023.
- Based on stone type, the calcium oxalate segment held the largest share in the market in 2023.
- Based on diagnostics, the ultrasound segment held a significant share of the market in 2023.
- Based on treatment, the extracorporeal shock wave lithotripsy- ESWL segment held the largest share in 2023 and dominated the kidney stone management market globally
- Based on end use, the hospitals segment held the largest market share and dominated the market.
- Based on end use, the specialty clinics segment is expected to experience the highest growth rate over the forecast period.
Get a Sample: https://www.precedenceresearch.com/sample/3941
Growth Factors:
Several factors contribute to the growth of the kidney stone management market. One significant factor is the rising incidence and prevalence of kidney stones worldwide. Factors such as dietary habits, dehydration, obesity, and genetic predisposition contribute to the increasing prevalence of kidney stones. Additionally, the aging population, which is more susceptible to kidney stone formation, further drives market growth. Moreover, technological advancements in imaging modalities such as ultrasound, CT scans, and MRI facilitate accurate diagnosis and monitoring of kidney stones, thereby boosting market growth. Furthermore, the increasing adoption of minimally invasive surgical techniques such as lithotripsy, ureteroscopy, and percutaneous nephrolithotomy (PCNL) drives the demand for kidney stone management devices and treatments.
Region Insights:
The kidney stone management market exhibits regional variations in terms of prevalence, treatment practices, and market dynamics. North America dominates the market owing to a high prevalence of kidney stones, favorable reimbursement policies, and the presence of key market players. In Europe, the market is driven by increasing awareness about kidney stone management and technological advancements in healthcare infrastructure. The Asia Pacific region is witnessing rapid market growth due to the rising prevalence of kidney stones in countries like China and India, coupled with improving healthcare infrastructure and increasing disposable income. Additionally, emerging economies in Latin America and the Middle East & Africa present untapped opportunities for market expansion due to improving access to healthcare and increasing investments in medical infrastructure.
Kidney Stone Management Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 5.47% |
| Global Market Size in 2023 | USD 2.73 Billion |
| Global Market Size by 2033 | USD 4.65 Billion |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Type of Stone, By Diagnostics Method, By Treatment, and By End-use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Kidney Stone Management Market Dynamics
Drivers:
Several drivers propel the growth of the kidney stone management market. Technological advancements in medical devices and treatments, such as the development of laser lithotripsy, shock wave lithotripsy (SWL), and minimally invasive surgical techniques, enhance the effectiveness and safety of kidney stone management procedures. Moreover, the growing demand for outpatient procedures and shorter hospital stays drives the adoption of minimally invasive treatments, contributing to market growth. Additionally, the increasing prevalence of risk factors such as obesity, sedentary lifestyle, and dietary habits rich in salt and protein fuels the incidence of kidney stones, thereby boosting market demand.
Opportunities:
The kidney stone management market presents several opportunities for growth and innovation. One such opportunity lies in the development of novel treatment modalities and devices that offer improved efficacy and fewer side effects compared to existing treatments. For instance, the emergence of targeted drug delivery systems and biodegradable stents holds promise for enhancing patient outcomes and reducing complications associated with traditional treatments. Moreover, expanding market penetration in emerging economies presents significant growth opportunities for market players to address the unmet medical needs of underserved populations. Additionally, strategic collaborations and partnerships between healthcare organizations, research institutions, and industry players can accelerate the development and commercialization of innovative kidney stone management solutions.
Challenges:
Despite the growth prospects, the kidney stone management market faces several challenges that may hinder market expansion. One major challenge is the high cost associated with advanced treatment modalities and medical devices, which limits access to care, particularly in developing regions. Additionally, regulatory hurdles and reimbursement limitations in certain markets pose challenges to market entry and product adoption. Moreover, the lack of skilled healthcare professionals proficient in performing minimally invasive procedures may impede the widespread adoption of advanced treatment options. Furthermore, patient non-compliance with treatment regimens and lifestyle modifications pose challenges to long-term management and prevention of kidney stones, highlighting the need for patient education and support programs.
Read Also: Facial Skincare Market Size to Cross USD 169.57 Billion by 2033
Recent Developments
- In June 2022, Olympus, a technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced the launch of the SoltiveTM SuperPulsed Laser System.
- In June 2022, Dornier MedTech and Endoluxe signed a multi-year exclusive distribution contract. Dornier and Endoluxe provide products and systems targeted toward the urology market, offering innovation and value.
Kidney Stone Management Market Companies
- Cook Medical Inc. (US)
- Boston Scientific Corporation (U.S.)
- Olympus Corp. (Japan)
- C.R. Bard Inc. (U.S.)
- Storz Medical AG (Switzerland)
- Richard Wolf GmbH (Germany)
- Lumenis (Israel)
- EDAP TMS (France)
- DirexGroup (Germany)
- Elmed Electronics & Medical Industry & Trade Inc. (Turkey)
- Medi spec Ltd. (U.S.)
- Convergent Laser Technologies (U.S.)
- E.M.S. Electro Medical Systems S.A. (Switzerland)
- Dornier MedTech GmbH (Germany)
- Stryker Corp. (U.S.)
- Olympus Corp. (Japan)
Segments Covered in the Report
By Type of Stone
- Calcium oxalate
- Calcium phosphate
- Uric acid
- Cysteine
- struvite
By Diagnostics Method
- Abdominal X-Ray
- Computed Tomography
- Ultrasound
- Abdominal MRI
- Intravenous Pyelography
- Others
By Treatment
- Extracorporeal Shock Wave Lithotripsy ESWL
- Ureteroscopy
- Percutaneous Nephrolithotomy PCNL
- Others
By End-use
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centres
- Other
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
